Tonix Pharmaceuticals is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X. Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Associate Director, Thought Leader Liaison (TLL), Fibromyalgia, will directly report into the Senior Director, Commercial Strategy and will lead executional efforts in regional and local engagement with existing and emerging Key Opinion Leaders (KOLs), Advocacy Groups and Professional Societies to develop and implement education that helps simplify the early Fibromyalgia patient journey from diagnosis through treatment and monitoring. This will include identifying new and emerging opinion leaders and appropriately engaging KOLs to support speaker bureau activities, and assessing speaker programs for meaningfulness, effectiveness, education, and compliance with company policies. The TLL role is a field-based role (non-sales focused) position, working closely with U.S. Key Fibromyalgia Thought Leaders (KOLs) to ensure cross-functional commercial resources are made available as appropriate. The three primary (but not exclusive) areas of focus for TLL are KOL engagement, executive encounter management, and supporting the Fibromyalgia community.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Associate degree